Prothena Corp plc Annual Meeting Results Approved
Ticker: PRTA · Form: 8-K · Filed: May 17, 2024 · CIK: 1559053
| Field | Detail |
|---|---|
| Company | Prothena Corp Public Ltd Co (PRTA) |
| Form Type | 8-K |
| Filed Date | May 17, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, annual-meeting
TL;DR
Prothena's AGM went smoothly, all votes passed, including director re-elections and auditor appointment.
AI Summary
On May 14, 2024, Prothena Corporation plc announced the results of its Annual General Meeting. Shareholders approved all proposed resolutions, including the re-election of directors and the appointment of PricewaterhouseCoopers as the company's auditor. The company also reported on its financial performance and business outlook.
Why It Matters
Shareholder approval of key resolutions, including director re-elections and auditor appointments, indicates continued confidence in Prothena's leadership and financial oversight.
Risk Assessment
Risk Level: low — The filing reports on routine corporate governance matters and meeting outcomes, with no new material risks disclosed.
Key Players & Entities
- Prothena Corporation plc (company) — Registrant
- PricewaterhouseCoopers (company) — Appointed Auditor
FAQ
What was the date of Prothena Corporation plc's Annual General Meeting?
The earliest event reported in the filing, related to the Annual General Meeting, was on May 14, 2024.
Were all proposed resolutions approved at the Annual General Meeting?
Yes, the filing indicates that shareholders approved all proposed resolutions.
Who was appointed as the company's auditor?
PricewaterhouseCoopers was appointed as the company's auditor.
What type of company is Prothena Corporation plc?
Prothena Corporation plc is a pharmaceutical preparations company, with SIC code 2834.
Where is Prothena Corporation plc headquartered?
Prothena Corporation plc is headquartered in Dublin, Ireland, with its business address at 77 Sir John Rogerson's Quay, Block C, Grand Canal Docklands, Dublin 2, D02 VK60.
Filing Stats: 883 words · 4 min read · ~3 pages · Grade level 11.6 · Accepted 2024-05-17 16:08:55
Key Financial Figures
- $0.01 — Registered Ordinary Shares, par value $0.01 per share PRTA The Nasdaq Global Select
Filing Documents
- prta-20240514.htm (8-K) — 55KB
- a2024mayxex101prtaxfiftham.htm (EX-10.1) — 6KB
- 0001559053-24-000017.txt ( ) — 192KB
- prta-20240514.xsd (EX-101.SCH) — 2KB
- prta-20240514_lab.xml (EX-101.LAB) — 23KB
- prta-20240514_pre.xml (EX-101.PRE) — 13KB
- prta-20240514_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On May 14, 2024, the Company held its Annual Meeting, at which the Company's shareholders voted on the following proposals, each of which is described in the Proxy Statement: Proposal No. 1: Election of Directors. The shareholders re-elected the following individuals to the Company's Board of Directors to hold office until no later than the annual general meeting of shareholders in 2027. Nominee For Against Abstain Broker Non-Votes Richard T. Collier 42,704,695 4,230,920 15,239 2,591,833 Shane M. Cooke 46,538,265 398,049 14,540 2,591,833 William H. Dunn, Jr. 46,769,850 165,930 15,074 2,591,833 Daniel G. Welch 40,327,963 6,608,319 14,572 2,591,833 Proposal No. 2: Ratification of Appointment of the Company's Independent Registered Public Accounting Firm for 2024 and Authorization of the Board of Directors to Approve the Remuneration of that Auditor. The shareholders ratified, in a non-binding vote, the appointment of KPMG LLP as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2024, and authorized, in a binding vote, the Company's Board of Directors, acting through its Audit Committee, to approve the remuneration of that auditor. For Against Abstain 49,433,824 63,084 45,779 Proposal No. 3: Approval of Compensation of the Company's Named Executive Officers. The shareholders approved, in a non-binding advisory vote, the compensation of the Company's executive officers named in the Proxy Statement. For Against Abstain Broker Non-Votes 45,331,500 425,331 1,194,023 2,591,833 Proposal No. 4: Approval of an Amendment to the Company's 2018 Long Term Incentive Plan. The shareholders approved the Amendment, which increases the number of ordinary shares available for issuance under the 2018 LTIP by 2,000,000 ordinary shares. For Against Abstain Broker Non-Votes 36,884,712 8,876,141 1,190,001 2,591,833
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 # Fifth Amendment to the Prothena Corporation plc 2018 Long Term Incentive Plan 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) # Indicates management contract or compensatory plan or arrangement.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 17, 2024 PROTHENA CORPORATION PLC By: /s/ Tran B. Nguyen Name: Tran B. Nguyen Title: Chief Strategy Officer and Chief Financial Officer